Solving The Protocol Deviation Puzzle With FDA Draft Guidance

by | Mar 14, 2025 | Clinical Trials | 0 comments

​ 

Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here, consultant Leila Cupersmith summarizes new FDA guidance on managing PDs.

 Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here, consultant Leila Cupersmith summarizes new FDA guidance on managing PDs. 

Submit a Comment

Your email address will not be published. Required fields are marked *